Preprint · OA via OpenAlex

Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose

Daniel L. Smith, Rachael M. Orlandella, David B. Allison, Lyse A. Norian

GeroScience · 2020 · ▲ 42 citations

Genomic instability Caloric restriction

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1007/s11357-020-00278-x
Canonical: link ↗
Fetched: 2026-06-29 MST

Cite this

APA

Smith, D.L., Orlandella, R.M., Allison, D.B., & Norian, L.A. (2020). Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose. <em>GeroScience</em>. https://doi.org/10.1007/s11357-020-00278-x

Vancouver

Smith DL, Orlandella RM, Allison DB, Norian LA. Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose. GeroScience. 2020. doi:10.1007/s11357-020-00278-x.

BibTeX

@unpublished{daniel2020Diabet, title = {Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose}, author = {Daniel L. Smith and Rachael M. Orlandella and David B. Allison and Lyse A. Norian}, journal = {GeroScience}, year = {2020}, doi = {10.1007/s11357-020-00278-x}, }